SEC14L2 blocking peptide product blogThe SEC14L2 sec14l2 (Catalog #MBS9221447) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The SEC14L2 sec14l2 product has the following accession number(s) (GI #21542232) (NCBI Accession #O76054.1) (Uniprot Accession #O76054). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Carrier protein. Binds to some hydrophobic molecules and promotes their transfer between the different cellular sites. Binds with high affinity to alpha-tocopherol. Also binds with a weaker affinity to other tocopherols and to tocotrienols. May have a transcriptional activatory activity via its association with alpha-tocopherol. Probably recognizes and binds some squalene structure, suggesting that it may regulate cholesterol biosynthesis by increasing the transfer of squalene to a metabolic active pool in the cell.
Cellular Location: Cytoplasm. Nucleus. Note: Cytoplasmic in absence of alpha-tocopherol, and nuclear in presence of alpha- tocopherol. Tissue Location: Widely expressed. Strong expression in liver, brain and prostate. Blood, Brain, Kidney, Liver, Lung, Lymph Node, Prostate, Testis, Umbilical Cord, Vascular tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Carcinoma, Hepatocellular, Inflammation, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Experimental, Nervous System Diseases, Prostatic Diseases are some of the diseases may be linked to SEC14L2 Antibody (N-term) Blocking Peptide.